Clinical Trial Update: Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating PAC-14028 cream for rosacea has completed. The trial was sponsored by Amorepacific Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythematotelangiectatic Rosacea
• Papulopustular Rosacea

Drugs mentioned

• PAC-14028 cream (PAC-14028)

Snippet

Sponsor: Amorepacific Corporation | Conditions: Erythematotelangiectatic Rosacea, Papulopustular Rosacea | Phase 2 | Status: COMPLETED